This was the major driver behind subjecting hma IL-10−/− mice to peroral menthol treatment starting a week before C. jejuni infections to monitor intestinal pathogen burdens, clinical, macroscopic, and microscopic complications of infection, as well as pro-inflammatory immune responses in the intestinal tract and beyond. This evidence concerns the gene IL10 and infection.